Showing results (1571-1580 of 1,700) with videos related to

Sort By:
Pageof 170
JACC. Cardiovascular Interventions|November 6, 2020
Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed TomographyOle De Backer, Uri Landes, Andreas Fuchs, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 2, 2020
The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS TrialMasafumi Ono, Ply Chichareon, Mariusz Tomaniak, et al.
Lancet (London, England)|August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.
JACC. Cardiovascular Interventions|October 29, 2025
Artificial Intelligence in Valvular Heart Disease: Innovations and Future DirectionsAnnette Maznyczka, Rutger-Jan Nuis, Isaac Shiri, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 4, 2021
Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX scorePly Chichareon, David van Klaveren, Rodrigo Modolo, et al.
BMJ (Clinical Research Ed.)|September 2, 2008
Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysisChristoph Stettler, Sabin Allemann, Simon Wandel, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 30, 2022
Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trialTaishi Okuno, George D Dangas, Christian Hengstenberg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 22, 2024
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromesDavide Cao, Pascal Vranckx, Marco Valgimigli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 16, 2025
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programmeAngelo Oliva, Dominick J Angiolillo, Marco Valgimigli, et al.
JAMA Cardiology|March 20, 2024
Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-AnalysisMarco Valgimigli, Felice Gragnano, Mattia Branca, et al.
Pageof 170